New surgical
knife can instantly detect cancer
A knife can
help surgeons make sure they removed all the cancerous tissue, doctors say.
By Maria Cheng. In USA Today
Big
Government Opens Big Database For Cancer ResearchSt.
For those of
us without degrees in molecular biology, the idea of “personalized medicine” –
or PM – can often seem like a vague and distant concept. In this case, the
Wikipedia definition of PM is pretty good:
“Personalized
medicine or PM is a medical model that proposes the customization of healthcare
– with medical decisions, practices, and/or products being tailored to the
individual patient. The use of genetic information has played a major role in
certain aspects of personalized medicine, and the term was even first coined in
the context of genetics (though it has since broadened to encompass all sorts
of personalization measures). To distinguish from the sense in which medicine
has always been inherently “personal” to each patient, PM commonly denotes the
use of some kind of technology or discovery enabling a level of personalization
not previously feasible or practical.”
By Dan Munro. In Forbes
Colorectal
Cancer Survivors May Face Risk Of Second Cancer
Researchers
from the University of Washington and Fred Hutchinson
Cancer Research
Center
By Amanda Chan. In Huffington Post
Finding
Cancer Cells in the Blood
Technologies
that can pull tumor cells from patients’ blood are giving researchers an
unprecedented look at cancer.
By Susan Young. In MIT Technology Review
Deaths Force
End to Celgene Trial to Expand Top Cancer Drug (1)
Celgene
Corp. (CELG:US) stopped a trial of Revlimid (lenalidomide), its biggest-selling
drug, after more people died using the product than those who were given a
competing therapy.
By Drew Armstrong. In BusinessWeek
Cancer : un scalpel
"intelligent" qui détecte les tissus atteints
Au cours des premiers
tests effectués, ce "e-scalpel" a détecté avec un taux de réussite de
100% les échantillons provenant de 91 patients.
Dans Atlantico.fr
Cancers en France : davantage de cas
mais une mortalité en baisse
Le nombre de cas de cancers en
France augmente depuis 1980. Mais la mortalité, elle, recule. Malgré tous les
progrès, 2012 est restée très meurtrière, puisque 148.000 hommes et femmes sont
décédés des suites de leur tumeur
Dans Futura Sciences
Aucun commentaire:
Enregistrer un commentaire